Bastien Guérin1,2, Jorge F Villena3, Athanasios G Polimeridis4, Elfar Adalsteinsson5,6, Luca Daniel5, Jacob K White5, Bruce R Rosen1,2,6, Lawrence L Wald1,2,6. 1. a Martinos Center for Biomedical Imaging, Department of Radiology , Massachusetts General Hospital , Charlestown , MA , USA. 2. b Harvard Medical School , Boston , MA , USA. 3. c Cadence Design Systems , Feldkirchen , Germany. 4. d Skolkovo Institute of Science and Technology , Moscow , Russia. 5. e Research Laboratory of Electronics , Massachusetts Institute of Technology , Cambridge , MA , USA. 6. f Harvard-MIT Division of Health Sciences Technology , Cambridge , MA , USA.
Abstract
PURPOSE: We introduce a method for calculation of the ultimate specific absorption rate (SAR) amplification factors (uSAF) in non-uniform body models. The uSAF is the greatest possible SAF achievable by any hyperthermia (HT) phased array for a given frequency, body model and target heating volume. METHODS: First, we generate a basis-set of solutions to Maxwell's equations inside the body model. We place a large number of electric and magnetic dipoles around the body model and excite them with random amplitudes and phases. We then compute the electric fields created in the body model by these excitations using an ultra-fast volume integral solver called MARIE. We express the field pattern that maximises the SAF in the target tumour as a linear combination of these basis fields and optimise the combination weights so as to maximise SAF (concave problem). We compute the uSAFs in the Duke body models at 10 frequencies in the 20-900 MHz range and for twelve 3 cm-diameter tumours located at various depths in the head and neck. RESULTS: For both shallow and deep tumours, the frequency yielding the greatest uSAF was ∼900 MHz. Since this is the greatest frequency that we simulated, we hypothesise that the globally optimal frequency is actually greater. CONCLUSIONS: The uSAFs computed in this work are very large (40-100 for shallow tumours and 4-17 for deep tumours), indicating that there is a large room for improvement of the current state-of-the-art head and neck HT devices.
PURPOSE: We introduce a method for calculation of the ultimate specific absorption rate (SAR) amplification factors (uSAF) in non-uniform body models. The uSAF is the greatest possible SAF achievable by any hyperthermia (HT) phased array for a given frequency, body model and target heating volume. METHODS: First, we generate a basis-set of solutions to Maxwell's equations inside the body model. We place a large number of electric and magnetic dipoles around the body model and excite them with random amplitudes and phases. We then compute the electric fields created in the body model by these excitations using an ultra-fast volume integral solver called MARIE. We express the field pattern that maximises the SAF in the target tumour as a linear combination of these basis fields and optimise the combination weights so as to maximise SAF (concave problem). We compute the uSAFs in the Duke body models at 10 frequencies in the 20-900 MHz range and for twelve 3 cm-diameter tumours located at various depths in the head and neck. RESULTS: For both shallow and deep tumours, the frequency yielding the greatest uSAF was ∼900 MHz. Since this is the greatest frequency that we simulated, we hypothesise that the globally optimal frequency is actually greater. CONCLUSIONS: The uSAFs computed in this work are very large (40-100 for shallow tumours and 4-17 for deep tumours), indicating that there is a large room for improvement of the current state-of-the-art head and neck HT devices.
Entities:
Keywords:
SAR amplification factor; Ultimate electromagnetics; frequency of the treatment energy; thermal dose; tumour depth
Authors: Jacek Nadobny; Horst Fähling; Mark J Hagmann; Paul F Turner; Waldemar Wlodarczyk; Johanna M Gellermann; Peter Deuflhard; Peter Wust Journal: IEEE Trans Biomed Eng Date: 2002-11 Impact factor: 4.538
Authors: J Gellermann; W Wlodarczyk; A Feussner; H Fähling; J Nadobny; B Hildebrandt; R Felix; P Wust Journal: Int J Hyperthermia Date: 2005-09 Impact factor: 3.914
Authors: J van der Zee; D González González; G C van Rhoon; J D van Dijk; W L van Putten; A A Hart Journal: Lancet Date: 2000-04-01 Impact factor: 79.321
Authors: Bart R Steensma; Ettore F Meliadò; Peter Luijten; Dennis W J Klomp; Cornelis A T van den Berg; Alexander J E Raaijmakers Journal: NMR Biomed Date: 2021-05-06 Impact factor: 4.044
Authors: Jan Redr; Tomas Pokorny; Tomas Drizdal; Ondrej Fiser; Matous Brunat; Jan Vrba; David Vrba Journal: Sensors (Basel) Date: 2022-08-16 Impact factor: 3.847